Peter E Westerweel - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Peter E Westerweel

Showing results (101-110 of 103) with videos related to

Pageof 11

Sort By:

You have reached the last page of results.This site can display upto 103 results.

Blood|June 26, 2023

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLLLina van der Straten, Claudia A M Stege, Sabina Kersting, et al.

Blood Advances|February 22, 2021

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trialBob Löwenberg, Thomas Pabst, Johan Maertens, et al.

JAMA|July 6, 2021

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis, Manu Shankar-Hari, Claire L Vale, et al.

Pageof 11

Search research articles

Showing results (101-110 of 103) with videos related to

Sort By:

Pageof 11

You have reached the last page of results.This site can display upto 103 results.

Blood|June 26, 2023

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLLLina van der Straten, Claudia A M Stege, Sabina Kersting, et al.

Blood Advances|February 22, 2021

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trialBob Löwenberg, Thomas Pabst, Johan Maertens, et al.

JAMA|July 6, 2021

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis, Manu Shankar-Hari, Claire L Vale, et al.

Pageof 11